CLINICAL TRIAL: A LONGITUDINAL STUDY OF MILD COGNITIVE IMPAIRMENT IN MS
临床试验:多发性硬化症轻度认知障碍的纵向研究
基本信息
- 批准号:7950778
- 负责人:
- 金额:$ 1.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-12-01 至 2009-11-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseClinicalClinical ResearchClinical TrialsCognitiveCognitive deficitsComputer Retrieval of Information on Scientific Projects DatabaseDeteriorationDevelopmentExhibitsFundingGoalsGrantImpaired cognitionInstitutionLongitudinal StudiesMeasurableOccupationalPatientsResearchResearch PersonnelResourcesRiskSocial ResponsibilitySourceUnited States National Institutes of Healthclinical caredisabilitymild neurocognitive impairmentolder patientsocioeconomics
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Cognitive dysfunction is a leading cause of disability in MS, exacting a tremendous socioeconomic and interpersonal toll. Unfortunately, the course of cognitive impairment in MS remains unclear. This study will focus specifically on patients currently exhibiting measurable cognitive deficits who are still engaged in occupational and social responsibilities. While the term mild cognitive impairment(MCI) has been used to identify elderly patients at risk for the development of Alzheimers disease, we believe the concept of MCI can be applied to a specific group of cognitive impaired patients with MS. The goal of this project is to evaluate the course of cognitive deterioration in MS patients receiving standard clinical care and to identify neuroradiological and clinical correlates of this cognitive decline.
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAUREN B KRUPP其他文献
LAUREN B KRUPP的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAUREN B KRUPP', 18)}}的其他基金
CLINICAL TRIAL: INTERVENTIONS TO IMPROVE MEMORY IN PATIENTS WITH MULTIPLE SCLERO
临床试验:改善多发性硬化症患者记忆力的干预措施
- 批准号:
7950797 - 财政年份:2008
- 资助金额:
$ 1.19万 - 项目类别:
CLINICAL TRIAL: NEUROLOGIC AND NEUROCOGNITIVE FEATURES OF MULTIPLE SCLEROSIS IN
临床试验:多发性硬化症的神经学和神经认知特征
- 批准号:
7950783 - 财政年份:2008
- 资助金额:
$ 1.19万 - 项目类别:
IMMUNOGENETIC STUDIES IN CHILDHOOD AND ADOLESCENT MULTIPLE SCLEROSIS
儿童和青少年多发性硬化症的免疫遗传学研究
- 批准号:
7950801 - 财政年份:2008
- 资助金额:
$ 1.19万 - 项目类别:
PROTEOMIC ANALYSIS OF PEDIATRIC MULTIPLE SCLEROSIS (MS), A PILOT STUDY
小儿多发性硬化症 (MS) 的蛋白质组学分析,一项试点研究
- 批准号:
7950800 - 财政年份:2008
- 资助金额:
$ 1.19万 - 项目类别:
PREDICTING COGNITIVE DECLINE IN MULTIPLE SCLEROSIS: THE ROLE OF NEGATIVE AFFECT
预测多发性硬化症的认知能力下降:负面情绪的作用
- 批准号:
7950842 - 财政年份:2008
- 资助金额:
$ 1.19万 - 项目类别:
INTERVENTIONS TO IMPROVE MEMORY IN PATIENTS WITH MULTIPLE SCLEROSIS
改善多发性硬化症患者记忆力的干预措施
- 批准号:
7607892 - 财政年份:2007
- 资助金额:
$ 1.19万 - 项目类别:
NEUROLOGIC AND NEUROCOGNITIVE FEATURES OF MULTIPLE SCLEROSIS IN CHILDREN
儿童多发性硬化症的神经学和神经认知特征
- 批准号:
7607861 - 财政年份:2007
- 资助金额:
$ 1.19万 - 项目类别:
IMMUNOGENETIC STUDIES IN CHILDHOOD AND ADOLESCENT MULTIPLE SCLEROSIS
儿童和青少年多发性硬化症的免疫遗传学研究
- 批准号:
7607897 - 财政年份:2007
- 资助金额:
$ 1.19万 - 项目类别:
A LONGITUDINAL STUDY OF MILD COGNITIVE IMPAIRMENT IN MS
多发性硬化症轻度认知障碍的纵向研究
- 批准号:
7607850 - 财政年份:2007
- 资助金额:
$ 1.19万 - 项目类别:
PROTEOMIC ANALYSIS OF PEDIATRIC MULTIPLE SCLEROSIS (MS), A PILOT STUDY
小儿多发性硬化症 (MS) 的蛋白质组学分析,一项试点研究
- 批准号:
7607896 - 财政年份:2007
- 资助金额:
$ 1.19万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 1.19万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 1.19万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 1.19万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 1.19万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 1.19万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 1.19万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 1.19万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 1.19万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 1.19万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 1.19万 - 项目类别: